Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedA new site revision, v3.6.2, replaces the previous v3.6.0, representing a minor update to the page's template/backend rather than content changes. This update does not affect the displayed study information, eligibility criteria, or enrollment details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now indicates that recruitment is closed and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), along with a minor heading formatting change for Intervention/Treatment and an updated revision label.SummaryDifference0.6%

- Check25 days agoChange DetectedThe page's revision indicator was updated from v3.5.4 to v3.5.5, signaling a small page update. No substantive changes to study details or content are evident from the changes shown.SummaryDifference0.1%

- Check32 days agoChange DetectedMelanoma is removed as a topic entry, the Related topics header is removed, and the MedlinePlus Genetics link is removed from the study page. These deletions reduce visible context and navigation related to the disease and genetics resources.SummaryDifference0.2%

- Check39 days agoChange DetectedAdded Melanoma as a topic and introduced a related topics section including MedlinePlus Genetics. These changes improve indexing and discoverability for users researching melanoma and genetics.SummaryDifference0.2%

- Check46 days agoChange DetectedRevision: v3.5.4 has been added, replacing the prior Revision: v3.5.3. This indicates a version update to the page content.SummaryDifference0.1%

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.